May 16
Current report
8-K
Events of May 13
Entered into a material agreement, Other events
PLSH · Panacea Life Sciences Holdings, Inc. · Documents
$0.08
At close · Nov 10
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 6, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital.”View the 10-Q filed May 6, 2024
Market Cap
$1.46M
Shares
17.65M
Volume · Nov 10
1123
Avg daily vol (3M)
6856
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2024
May 7
Current report
8-K
Events of May 3
Change of auditor
May 6
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $1.06M
▲ 55.9%
Net loss $1.45M
Diluted EPS -$0.09
Apr 1
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Revenue $2.38M
▲ 46.6%
Net loss $8.02M
Diluted EPS -$0.48
Mar 7
Current report
8-K
Events of Mar 5
Entered into a material agreement, New debt or off-balance-sheet obligation
Feb 5
Current report
8-K
Events of Jan 29
Entered into a material agreement
2023
Dec 8
Current report
8-K/A
Events of Sep 30
Completed an acquisition or sale of assets
Nov 14
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $347.85K
▼ 5.0%
Net loss $2.15M
Diluted EPS -$0.13
Oct 5
Oct 2
Current report
8-K
Entered into a material agreement, Other events
Aug 15
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $399.13K
▼ 15.0%
Net loss $1.86M
Diluted EPS -$0.11
Aug 15
Late filing notice
NT 10-Q
Late filing notice
Jul 10
Current report
8-K
Events of Jul 3
Entered into a material agreement, Regulation FD disclosure
Jun 2
Current report
8-K
Events of May 26
Director or officer change, or executive pay
May 12
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $677.48K
▲ 45.2%
Net loss $1.79M
Mar 30
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Revenue $1.63M
▼ 21.0%
Net loss $9.14M
Feb 14
Current report
8-K
Entered into a material agreement, New debt or off-balance-sheet obligation
Jan 23
Current report
8-K
Other events
2022
Dec 27
Current report
8-K
Events of Dec 21
Entered into a material agreement, New debt or off-balance-sheet obligation
Nov 14
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $366.24K
▼ 37.7%
Net loss $2.69M
Aug 15
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $469.47K
▲ 49.8%
Net loss $1.96M
Jul 22
Current report
8-K
Events of Jul 21
Director or officer change, or executive pay
Jun 27
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2021
Jun 10
Current report
8-K
Events of Jun 8
Regulation FD disclosure
May 18
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2021
May 13
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $466.47K
▼ 8.9%
Net loss $2.78M
Diluted EPS -$0.19
May 3
Current report
8-K
Regulation FD disclosure
Apr 29
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2021
Mar 31
Annual report
10-K
FY2021, ended Dec 31
Annual report for FY2021
Revenue $2.06M
▼ 77.2%
Net loss $4.78M
Mar 4
Current report
8-K
Events of Mar 3
Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity
2021
Dec 29
Current report
8-K
Events of Dec 28
Change of auditor
Dec 20
Quarterly report
10-Q/A
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $313.5K
▼ 94.9%
Net income $27.21K
▼ 95.8%
Diluted EPS $0.00
Dec 20
Quarterly report
10-Q/A
FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $588.04K
▼ 56.2%
Net loss $3.09M
Diluted EPS -$0.14
Dec 20
Current report
8-K
Events of Dec 17
Earlier financial statements no longer reliable
Dec 17
Current report
8-K/A
Other events
Dec 17
Quarterly report
10-Q/A
Ended Jun 30
Quarterly report for the period ended Jun 30, 2021
Dec 17
Quarterly report
10-Q/A
Ended Sep 30
Quarterly report for the period ended Sep 30, 2021
Dec 1
Current report
8-K
Events of Nov 30
Entered into a material agreement
Nov 24
Current report
8-K
Events of Nov 18
Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity
Nov 22
Quarterly report
10-Q
FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $588.04K
▼ 56.2%
Net loss $3.17M
Nov 16
Late filing notice
NT 10-Q
Late filing notice
Oct 29
Current report
8-K
Events of Oct 25
Director or officer change, or executive pay
Oct 21
Current report
8-K
Events of Oct 17
Director or officer change, or executive pay
Sep 16
Current report
8-K
Events of Sep 10
Earlier financial statements no longer reliable
Aug 23
Quarterly report
10-Q
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $5.07M
▼ 18.4%
Net income $124.53K
▼ 79.9%
Diluted EPS $0.00
Aug 17
Late filing notice
NT 10-Q
Late filing notice
Jul 8
Current report
8-K
Regulation FD disclosure
Jul 7
Jun 29
May 27
Quarterly report
10-Q/A
FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $0
Net loss $5.01M
Showing 1–50 of 88 documents